Government Affairs Manager
About the job
- A university degree in a relevant field such as public policy, law, political science, economics, public administration, health policy, or a related discipline is required.
- Five to eight years of professional experience in environments directly involved in public policy shaping, preferably within public institutions, ministerial or parliamentary offices, political advisory roles, regulatory bodies, trade associations, think tanks, media, or other policy-facing stakeholder organizations.
- A strong strategic mindset and business acumen, with analytical, problem-solving, and judgment skills and the ability to operate in a complex, fast-paced, and evolving environment.
- Demonstrated exposure to policymaking, stakeholder influence, and public affairs dynamics; pharmaceutical experience is not essential.
- A strong understanding of policy development processes, institutional decision-making, and stakeholder landscapes, ideally within the Polish context.
- The ability to build and maintain credible relationships with senior stakeholders across government, the public sector, and broader policy ecosystems.
- Strong strategic communication skills and the ability to translate complex policy issues into clear, credible, and compliant messages.
- Demonstrated capability in stakeholder management, issue analysis, and cross-functional collaboration.
- The ability to work effectively in a matrix organization while managing multiple priorities with professionalism and discretion.
- Fluency in English at executive or business level.
- Develop and execute government affairs strategies that contribute to a predictable, patient-centered, and innovation-friendly policy and regulatory environment in Poland.
- Monitor, analyze, and engage on policy, legislative, and regulatory developments that may affect patient access, market conditions, and long-term business objectives.
- Contribute to efforts to strengthen the value and recognition of innovative medicines within the healthcare system and support sustainable access frameworks in a changing reimbursement environment.
- Build and maintain trusted relationships with external stakeholders, including government institutions, policymakers, healthcare authorities, trade associations, and other relevant opinion leaders.
- Maintain an understanding of the healthcare landscape, stakeholder priorities, and emerging policy trends to inform strategic decisions and identify risks and opportunities.
- Identify strategic issues, develop advocacy positions, and support targeted engagement plans that advance business and policy objectives.
- Work with Market Access, Medical, Legal, Communications, and Commercial teams to ensure aligned messaging, coordinated planning, and compliant execution of external affairs activities.
- Represent AbbVie in relevant external forums, industry platforms, and stakeholder dialogues.
- Support affiliate prioritization by translating policy developments into actionable recommendations and identifying strategic trade-offs.
- Share local insights and contribute to the regional and global government affairs network, aligning with enterprise priorities and sharing best practices.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget